Cubist Pharmaceuticals may pay up to $341.5 million to buy Illumigen Biosciences, adding an experimental...
Noven Pharmaceuticals Thursday announced that the Food and Drug Administration has issued a tentative approval...
A letter published in the Dec. 27 issue of the New England Journal of Medicine...
Officials at the U.S. Centers for Disease Control and Prevention said last week that the...
Wyeth Pharmaceuticals announced that they have received a second approvable letter for Bazedoxifene from the...
The Food and Drug Administration issued an approvable letter for Jazz Pharmaceuticals’ Once-a-Day Luvox CR...
Pfizer announced this week that the Food and Drug Administration has issued them an approvable...
Despite the lack of a White House-requested I.T. mandate, President Bush has said that he...
In a deal worth a reported $3 billion-plus, One Equity Partners’ stake in drug trial...
Despite having a patent in place until 2010, Wyeth was forced to go to court...
Abbott Laboratories announced that the European Commission approved the marketing of Humira as a treatment...
The Employers Coalition for Healthcare Options released a new report on the prevalence, cost and...
The Food and Drug Administration has sent a second approvable letter to Neurocrine Biosciences informing...
The Food and Drug Administration has issued its second safety warning about all fentanyl transdermal...
Florida Gov. Charlie Crist announced yesterday a new prescription discount card for seniors and others...
Genentech has resolved a dispute with ophthalmologists over the use of its cancer drug Avastin,...
The Generic Pharmaceutical Association has openly applauded Congress for approving a $6 million increase in...
GlaxoSmithKline has filed a new drug application with the Food and Drug Administration to market...
The biopharmaceutical company Regeneron Pharmaceuticals said yesterday that it closed a $312 million common stock...
Respironics on Friday announced a definitive merger agreement with Royal Philips Electronics, which will commence...
Reporter Sabine Vollmer, biotechnology and pharmacy staff writer, with The News & Observer in Raleigh,...
Teva announced today the availability of its new drug ceftriaxone for injection....
Valeant Pharmaceuticals has agreed to sell its U.S. and Canadian rights to its hepatitis C...
Walgreens Friday announced record sales and earnings for the first quarter of fiscal year 2008....
Biogen Idec announced Thursday that Escoublac would be the first company to join its Innovation...